Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria

[1]  M. Good.  Towards a blood-stage vaccine for malaria: are we following all the leads? , 2001, Nature Reviews Immunology.

[2]  Huji Xu,et al.  Apoptotic Deletion of Th Cells Specific for the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein 1 During Malaria Infection1 , 2001, The Journal of Immunology.

[3]  A. Hill,et al.  Vaccines against intracellular infections requiring cellular immunity , 2000, Nature.

[4]  F. Finkelman,et al.  Malaria parasite‐specific Th1‐like T cells simultaneously reduce parasitemia and promote disease , 1999, Parasite immunology.

[5]  A. Holder,et al.  Passive Immunization with Antibodies against Three Distinct Epitopes on Plasmodium yoelii Merozoite Surface Protein 1 Suppresses Parasitemia , 1998, Infection and Immunity.

[6]  J. Berzofsky,et al.  Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP119) and their role in immunity to malaria , 1998, Parasite immunology.

[7]  K. Mendis,et al.  Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for HumanPlasmodium vivax Malaria , 1998, Infection and Immunity.

[8]  C. Hirunpetcharat,et al.  Deletion of Plasmodium berghei-specific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Fandeur,et al.  Variant- and strain-specific immunity in Saimiri infected with Plasmodium falciparum. , 1998, The American journal of tropical medicine and hygiene.

[10]  R. Anders,et al.  A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design. , 1997, Journal of immunology.

[11]  J. Berzofsky,et al.  Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effect , 1997, Journal of immunology.

[12]  A. Holder,et al.  Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds , 1997, Infection and immunity.

[13]  D. Kaslow,et al.  Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii , 1997, Infection and immunity.

[14]  M. Good,et al.  Prolonged Th1‐like response generated by a Plasmodium yoeli‐specific T cell clone allows complete clearance of infection in reconstituted mice , 1997, Parasite immunology.

[15]  J. Berzofsky,et al.  Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. , 1996, Journal of immunology.

[16]  P. Barr,et al.  A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria , 1996, Infection and immunity.

[17]  O. Branch,et al.  Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. , 1995, Journal of immunology.

[18]  D. Kaslow,et al.  Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae. , 1994, Journal of immunology.

[19]  A. Taylor-Robinson,et al.  Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection , 1994, European journal of immunology.

[20]  P. Barr,et al.  A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. , 1992, Journal of immunology.

[21]  A. Holder,et al.  Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. , 1991, Molecular and biochemical parasitology.

[22]  H. Whittle,et al.  Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. , 1991, Molecular and biochemical parasitology.

[23]  A. Holder,et al.  A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion- inhibiting antibodies , 1990, The Journal of experimental medicine.

[24]  A. Lewis.  Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoelii. , 1989, Molecular and biochemical parasitology.

[25]  G. Hui,et al.  Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Holder,et al.  Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum , 1987, Parasitology.

[27]  J. McBride,et al.  Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. , 1987, Molecular and biochemical parasitology.

[28]  G. Campbell,et al.  Stage-specific and species-specific antigens of Plasmodium vivax and Plasmodium ovale defined by monoclonal antibodies , 1986, Infection and immunity.

[29]  J. Weber,et al.  Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Holder,et al.  Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen. , 1983, Clinical and experimental immunology.

[31]  T. Daly,et al.  Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge. , 1999, Experimental parasitology.